Loss of the peritoneal dialysis (PD) catheter is a major cause of PD technique failure and transfer to hemodialysis. In the present study, we report our experience with permanent peritoneal catheters. We prospectively analyzed 125 double-cuff coiled, swan-neck catheters implanted by the open surgical method in 120 patients from January 1996 to June 2003. The patients were evaluated monthly and followed for a total of 2806 patient-months. The mean age of the patients was 55 +/- 17 years (range: 22 - 91 years); 52% were men; 20% had diabetes; 10% were receiving immunosuppressive treatment; 45% were Staphylococcus aureus nasal carriers; and 93.3% were on automated PD. Catheter survival was 97% at 2 years and 92.2% at 5 years. A total of 59 early and late catheter complications were observed in 36 patients. These included exit-site infection at a rate of 0.125 episodes/ patient-year. The most frequent noninfectious complications were herniation (8%), leakage (6%), and bloody dialysate (3%). Statistical analysis did not identify variables that predicted the development of exit-site infection. The overall peritonitis rate was 0.149 episodes/patient-year. Our data suggest that the main catheter complication is infection. The low incidence of infection in our study is probably related more to good installation technique and aftercare than to the clinical characteristics of the patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

peritoneal dialysis
8
catheter survival
8
exit-site infection
8
catheter
5
patients
5
outcome peritoneal
4
dialysis tenckhoff
4
tenckhoff catheter
4
survival prospective
4
prospective study
4

Similar Publications

Background And Aims: The COVID-19 pandemic impacted greatest among patients with pre-existing chronic health conditions, including chronic kidney disease. This retrospective cohort study aimed to investigate the 30-day mortality of patients receiving kidney replacement therapy (KRT) after infection with COVID-19, living in Australia and New Zealand between 2020 and 2022, including patients on haemodialysis (HD), peritoneal dialysis (PD) and renal transplant (KT) recipients.

Methods: This is a retrospective cohort study using data from the Australian and New Zealand Dialysis and Transplant Registry (ANZDATA).

View Article and Find Full Text PDF

Hypertension in chronic kidney disease patients is very common. The definition of resistant hypertension in the general population is as follows: uncontrolled blood pressure (BP) on three or more hypotensive agents in adequate doses, or when patients are on four or more hypotensive agent categories irrespective of the BP control, with diuretics included in the therapy. However, these resistant hypertension definitions do not apply to the setting of end-stage kidney disease.

View Article and Find Full Text PDF

Economic analysis of hemodialysis and urgent-start peritoneal dialysis therapies.

J Bras Nefrol

January 2025

Universidade Estadual Paulista, Faculdade de Medicina, Departamento de Clínica Médica, Botucatu, SP, Brazil.

Introduction: Unplanned initiation of renal replacement therapy (RRT) in chronic kidney disease (CKD) patients is a common situation worldwide. In this scenario, peritoneal dialysis (PD) has emerged as a therapeutic option compared to hemodialysis (HD). In planned RRT, the costs of PD are lower than those of HD; however, the literature lacks such analyses when initiation is urgent.

View Article and Find Full Text PDF

Introduction: In chronic kidney disease (CKD) patients, elevated parathyroid hormone (PTH) is linked to cardiovascular mortality and morbidity. Levels of PTH are influenced by serum phosphate (P) and calcium (Ca), but little is known about the impact of magnesium (Mg) on PTH. Hence, this study investigated the relationship between PTH and Mg in peritoneal dialysis (PD) patients and non-dialysis patients from three hospitals in China.

View Article and Find Full Text PDF

Rationale & Objective: Peritoneal dialysis (PD) solutions provide both clearance of uremic toxins and sodium and water. An intraperitoneal (IP) solution of icodextrin and glucose designed without the requirement for uremic toxin clearance could provide substantially greater sodium and water removal than PD solutions.

Study Design: We examined varying concentrations of icodextrin and dextrose IP solutions in rats.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!